SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (22598)6/22/1998 9:38:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Bob, I was the scientific founder of Progenx in 1987. In 1988, Ron Evans' technology was exclusively licensed by Progenx from the Salk. In 1989 Progenx became Ligand.

Ron Evans published the first IR sequence in 1985. It was the sequence of the glucocorticoid receptor and was soon followed by many more sequences (most of the early sequences came out of Ron Evans' lab and he has been an exclusive consultant to Ligand ever since the technology was licensed in 1988).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext